PRESTIGE CONSUMER HEALTHCARE INC. Investing Cash Flow
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Investing Cash Flow of -$1.06 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$1.06B.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.41M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$128.56M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.93M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for fiscal 2026 was -$136.84M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for fiscal 2025 was -$17.45M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for fiscal 2024 was -$20.11M.
- PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) investing activities for fiscal 2023 was -$11.58M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.06B 10-Q · filed 2026-08-06 | -$1.07B derived: sum of 2 quarters · filed 2026-08-06 | -$1.20B derived: sum of 3 quarters · filed 2026-08-06 | -$1.20B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | -$131.97M derived: sum of 2 quarters · filed 2026-05-14 | -$134.90M derived: sum of 3 quarters · filed 2026-05-14 | -$136.84M 10-K · filed 2026-05-14 |
| 2025-12-31 | -$128.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | -$131.49M derived: sum of 2 quarters · filed 2026-02-05 | -$133.43M 10-Q · filed 2026-02-05 | -$136.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | -$2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$4.87M 10-Q · filed 2025-11-06 | -$8.35M derived: sum of 3 quarters · filed 2026-08-06 | -$18.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.94M 10-Q · filed 2026-08-06 | -$5.42M derived: sum of 2 quarters · filed 2026-08-06 | -$15.23M derived: sum of 3 quarters · filed 2026-08-06 | -$17.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | -$13.29M derived: sum of 2 quarters · filed 2026-05-14 | -$15.32M derived: sum of 3 quarters · filed 2026-05-14 | -$17.45M 10-K · filed 2026-05-14 |
| 2024-12-31 | -$9.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05 | -$11.84M derived: sum of 2 quarters · filed 2026-02-05 | -$13.97M 10-Q · filed 2026-02-05 | -$28.98M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-09-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$4.16M 10-Q · filed 2025-11-06 | -$19.16M derived: sum of 3 quarters · filed 2026-05-14 | -$23.66M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-06-30 | -$2.13M 10-Q · filed 2025-08-07 | -$17.13M derived: sum of 2 quarters · filed 2026-05-14 | -$21.63M derived: sum of 3 quarters · filed 2026-05-14 | -$24.56M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-03-31 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | -$19.50M derived: sum of 2 quarters · filed 2026-05-14 | -$22.43M derived: sum of 3 quarters · filed 2026-05-14 | -$20.11M 10-K · filed 2026-05-14 |
| 2023-12-31 | -$4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | -$7.43M derived: sum of 2 quarters · filed 2025-02-06 | -$5.11M 10-Q · filed 2025-02-06 | -$11.46M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-09-30 | -$2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$611.00K 10-Q · filed 2024-11-07 | -$6.97M derived: sum of 3 quarters · filed 2025-05-09 | -$8.77M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-06-30 | $2.32M 10-Q · filed 2024-08-08 | -$4.04M derived: sum of 2 quarters · filed 2025-05-09 | -$5.84M derived: sum of 3 quarters · filed 2025-05-09 | -$8.21M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-03-31 | -$6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09 | -$8.16M derived: sum of 2 quarters · filed 2025-05-09 | -$10.54M derived: sum of 3 quarters · filed 2025-05-09 | -$11.58M 10-K · filed 2025-05-09 |
| 2022-12-31 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$4.18M derived: sum of 2 quarters · filed 2024-02-08 | -$5.23M 10-Q · filed 2024-02-08 | -$8.52M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-09-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-02 | -$3.42M 10-Q · filed 2023-11-02 | -$6.72M derived: sum of 3 quarters · filed 2024-05-15 | -$26.95M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-06-30 | -$1.05M 10-Q · filed 2023-08-03 | -$4.34M derived: sum of 2 quarters · filed 2024-05-15 | -$24.57M derived: sum of 3 quarters · filed 2024-05-15 | -$256.24M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-03-31 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15 | -$23.52M derived: sum of 2 quarters · filed 2024-05-15 | -$255.19M derived: sum of 3 quarters · filed 2024-05-15 | -$256.51M 10-K · filed 2024-05-15 |
| 2021-12-31 | -$20.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-02 | -$251.90M derived: sum of 2 quarters · filed 2023-02-02 | -$253.22M 10-Q · filed 2023-02-02 | -$258.11M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-09-30 | -$231.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | -$232.99M 10-Q · filed 2022-11-03 | -$237.88M derived: sum of 3 quarters · filed 2023-05-05 | -$243.61M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-06-30 | -$1.32M 10-Q · filed 2022-08-04 | -$6.22M derived: sum of 2 quarters · filed 2023-05-05 | -$11.95M derived: sum of 3 quarters · filed 2023-05-05 | -$21.01M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-03-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05 | -$10.62M derived: sum of 2 quarters · filed 2023-05-05 | -$19.69M derived: sum of 3 quarters · filed 2023-05-05 | -$22.24M 10-K · filed 2023-05-05 |
| 2020-12-31 | -$5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | -$14.79M derived: sum of 2 quarters · filed 2022-02-03 | -$17.35M 10-Q · filed 2022-02-03 | -$25.61M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-09-30 | -$9.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | -$11.62M 10-Q · filed 2021-11-04 | -$19.88M derived: sum of 3 quarters · filed 2022-05-06 | -$22.37M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-06-30 | -$2.55M 10-Q · filed 2021-08-05 | -$10.82M derived: sum of 2 quarters · filed 2022-05-06 | -$13.30M derived: sum of 3 quarters · filed 2022-05-06 | -$17.17M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-03-31 | -$8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-06 | -$10.75M derived: sum of 2 quarters · filed 2022-05-06 | -$14.61M derived: sum of 3 quarters · filed 2022-05-06 | -$16.57M 10-K · filed 2022-05-06 |
| 2019-12-31 | -$2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04 | -$6.35M derived: sum of 2 quarters · filed 2021-02-04 | -$8.30M 10-Q · filed 2021-02-04 | -$11.65M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-09-30 | -$3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | -$5.82M 10-Q · filed 2020-11-05 | -$9.16M derived: sum of 3 quarters · filed 2021-05-07 | -$11.23M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-06-30 | -$1.96M 10-Q · filed 2020-08-06 | -$5.30M derived: sum of 2 quarters · filed 2021-05-07 | -$7.36M derived: sum of 3 quarters · filed 2021-05-07 | $55.95M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-03-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-07 | -$5.41M derived: sum of 2 quarters · filed 2021-05-07 | $57.90M derived: sum of 3 quarters · filed 2021-05-07 | $55.43M 10-K · filed 2021-05-07 |
| 2018-12-31 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-06 | $61.24M derived: sum of 2 quarters · filed 2020-02-06 | $58.77M 10-Q · filed 2020-02-06 | $55.90M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-09-30 | $63.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-10-31 | $60.84M 10-Q · filed 2019-10-31 | $57.96M derived: sum of 3 quarters · filed 2020-05-08 | $53.09M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-06-30 | -$2.47M 10-Q · filed 2019-08-01 | -$5.34M derived: sum of 2 quarters · filed 2020-05-08 | -$10.22M derived: sum of 3 quarters · filed 2020-05-08 | -$12.45M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-03-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | -$7.75M derived: sum of 2 quarters · filed 2020-05-08 | -$9.98M derived: sum of 3 quarters · filed 2020-05-08 | -$11.56M 10-K · filed 2020-05-08 |
| 2017-12-31 | -$4.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | -$7.10M derived: sum of 2 quarters · filed 2019-02-07 | -$8.69M 10-Q · filed 2019-02-07 | -$813.57M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-09-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-01 | -$3.81M 10-Q · filed 2018-11-01 | -$808.70M derived: sum of 3 quarters · filed 2019-05-13 | -$749.43M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-06-30 | -$1.58M 10-Q · filed 2018-08-02 | -$806.47M derived: sum of 2 quarters · filed 2019-05-13 | -$747.20M derived: sum of 3 quarters · filed 2019-05-13 | -$695.28M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-03-31 | -$804.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-13 | -$745.62M derived: sum of 2 quarters · filed 2019-05-13 | -$693.70M derived: sum of 3 quarters · filed 2019-05-13 | -$694.60M 10-K · filed 2019-05-13 |
| 2016-12-31 | $59.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $111.18M derived: sum of 2 quarters · filed 2018-02-01 | $110.29M 10-Q · filed 2018-02-01 | -$117.73M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-09-30 | $51.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | $51.02M 10-Q · filed 2017-11-02 | -$176.99M derived: sum of 3 quarters · filed 2018-05-10 | -$170.61M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-06-30 | -$895.00K 10-Q · filed 2017-08-03 | -$228.91M derived: sum of 2 quarters · filed 2018-05-10 | -$222.53M derived: sum of 3 quarters · filed 2018-05-10 | -$223.43M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-03-31 | -$228.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10 | -$221.63M derived: sum of 2 quarters · filed 2018-05-10 | -$222.53M derived: sum of 3 quarters · filed 2018-05-10 | -$222.97M 10-K · filed 2018-05-10 |
| 2015-12-31 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-02 | $5.48M derived: sum of 2 quarters · filed 2017-02-02 | $5.04M 10-Q · filed 2017-02-02 | $2.64M derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-09-30 | -$903.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | -$1.34M 10-Q · filed 2016-11-03 | -$3.74M derived: sum of 3 quarters · filed 2017-05-17 | $3.94M derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-06-30 | -$436.00K 10-Q · filed 2016-08-04 | -$2.84M derived: sum of 2 quarters · filed 2017-05-17 | $4.84M derived: sum of 3 quarters · filed 2017-05-17 | -$727.21M derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-03-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-17 | $5.28M derived: sum of 2 quarters · filed 2017-05-17 | -$726.77M derived: sum of 3 quarters · filed 2017-05-17 | -$805.26M 10-K · filed 2017-05-17 |
| 2014-12-31 | $7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | -$724.37M derived: sum of 2 quarters · filed 2016-02-04 | -$802.86M 10-Q · filed 2016-02-04 | -$802.96M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-09-30 | -$732.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05 | -$810.54M 10-Q · filed 2015-11-05 | -$810.64M derived: sum of 3 quarters · filed 2016-05-17 | -$810.98M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-06-30 | -$78.49M 10-Q · filed 2015-08-06 | -$78.59M derived: sum of 2 quarters · filed 2016-05-17 | -$78.93M derived: sum of 3 quarters · filed 2016-05-17 | -$135.10M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-03-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-17 | -$445.00K derived: sum of 2 quarters · filed 2016-05-17 | -$56.61M derived: sum of 3 quarters · filed 2016-05-17 | -$57.98M 10-K · filed 2016-05-17 |
| 2013-12-31 | -$339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | -$56.51M derived: sum of 2 quarters · filed 2015-02-05 | -$57.87M 10-Q · filed 2015-02-05 | -$59.22M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-09-30 | -$56.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | -$57.53M 10-Q · filed 2014-11-06 | -$58.88M derived: sum of 3 quarters · filed 2015-05-14 | -$40.83M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-06-30 | -$1.36M 10-Q · filed 2014-08-07 | -$2.71M derived: sum of 2 quarters · filed 2015-05-14 | $15.34M derived: sum of 3 quarters · filed 2015-05-14 | $11.27M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-03-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14 | $16.70M derived: sum of 2 quarters · filed 2015-05-14 | $12.63M derived: sum of 3 quarters · filed 2015-05-14 | $11.22M 10-K · filed 2015-05-14 |
| 2012-12-31 | $18.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07 | $13.98M derived: sum of 2 quarters · filed 2014-02-07 | $12.57M 10-Q · filed 2014-02-07 | -$650.48M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-09-30 | -$4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-07 | -$5.48M 10-Q · filed 2013-11-07 | -$668.52M derived: sum of 3 quarters · filed 2014-05-19 | -$668.58M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-06-30 | -$1.41M 10-Q · filed 2013-08-01 | -$664.46M derived: sum of 2 quarters · filed 2014-05-19 | -$664.51M derived: sum of 3 quarters · filed 2014-05-19 | -$663.54M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-03-31 | -$663.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | -$663.10M derived: sum of 2 quarters · filed 2014-05-19 | -$662.13M derived: sum of 3 quarters · filed 2014-05-19 | -$662.21M 10-K · filed 2014-05-19 |
| 2011-12-31 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07 | $918.00K derived: sum of 2 quarters · filed 2013-02-07 | $842.00K 10-Q · filed 2013-02-07 | -$76.51M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-09-30 | $969.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $893.00K 10-Q · filed 2012-11-07 | -$76.46M derived: sum of 3 quarters · filed 2013-05-17 | -$278.65M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-06-30 | -$76.00K 10-Q · filed 2012-08-09 | -$77.43M derived: sum of 2 quarters · filed 2013-05-17 | -$279.62M derived: sum of 3 quarters · filed 2013-05-17 | -$275.63M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-03-31 | -$77.35M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-17 | -$279.55M derived: sum of 2 quarters · filed 2013-05-17 | -$275.55M derived: sum of 3 quarters · filed 2013-05-17 | -$275.68M 10-K · filed 2013-05-17 |
| 2010-12-31 | -$202.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-09 | -$198.20M derived: sum of 2 quarters · filed 2012-02-09 | -$198.33M 10-Q · filed 2012-02-09 | |
| 2010-09-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $3.87M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$130.00K 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $7.32M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |